Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | FPHAX Insights | FPHAX Score | FPHAX Performance | FPHAX News | FPHAX Allocation | FPHAX Holdings Change

Fidelity Select Pharmaceuticals Port (FPHAX) Fund Ranking and Research

Ranking, Research and Recommendation of Fidelity Select Pharmaceuticals Port (FPHAX) Fund

    Last Trade: $22.81 on 8/31/2015, Change: -0.32 (-1.38%)

 

Graph of Fidelity Select Pharmaceuticals Port Fund (FPHAX) ManagerFund Manager - Asher Anolic

Fund Manager Information

Fund Manager Tenure: 2.4 years
Fund Family: Fidelity Investments
Fund Category: Health
Fund Performance: Jul 30, 2015
Fundmojo Fund Grade: B (Score: 0.66)     (What does this score mean?)

 

Graph of Fidelity Select Pharmaceuticals Port Fund (FPHAX) ProfileFidelity Select Pharmaceuticals Port Fund (FPHAX) Profile

Fund Profile and Description

Fidelity Select Pharmaceuticals Port Fund seeks capital appreciation. Fidelity Select Pharmaceuticals Port Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. These companies may include pharmaceutical companies and other companies involved in the research, development, manufacture, sale, or distribution of drugs, including companies that facilitate the testing or regulatory approval of drugs. It may invest in securities of foreign issuers. Fidelity Select Pharmaceuticals Port Fund is non-diversified.

 

Fidelity Select Pharmaceuticals Port (FPHAX) Fund Strength What we like about Fidelity Select Pharmaceuticals Port (FPHAX) Fund

Data for Fidelity Select Pharmaceuticals Port Fund (FPHAX) as of Jul 30, 2015

  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) has good Long-term performance (5-year return 26.55% vs 25.32% Health category median performance)
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) ratio of up-years vs down years is greater than 2
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) has a Morningstar rating of 4 and above
  • Asset base in Fidelity Select Pharmaceuticals Port Fund (FPHAX) has been consistently increasing at a reasonable pace in the last 2 months. It shows investor confidence and market support
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) is less volatile than its peers as it has a 3-year Standard Deviation of 10.16, lower than category average of 12.5
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) has a lower expense ratio than its Health average: 0.79% vs 1.36%
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

Fidelity Select Pharmaceuticals Port Fund (FPHAX) Weakness What we are cautious about Fidelity Select Pharmaceuticals Port (FPHAX) Fund

Data for Fidelity Select Pharmaceuticals Port Fund (FPHAX) as of Jul 30, 2015

  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) management has been with Fidelity Select Pharmaceuticals Port Fund for only 2.4 years, it is hard to judge manager's ability based on this fund's operation record
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) has a less-than-ideal short-term performance (1-year return 33.92% vs 34.62% Health category median performance)
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) has a less-than-ideal mid-term performance (3-year return 29.79% vs 31.58% Health category median performance)
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) is less safe compared to its Health peers
  • Fidelity Select Pharmaceuticals Port Fund (FPHAX) has an annual stock turnover rate of 72.00% that is higher than the Health average of 47.77%. This could mean Fidelity Select Pharmaceuticals Port is more nimble, but also signal potential high tax impact and high trading fees
  • As a Health focused fund, Fidelity Select Pharmaceuticals Port Fund (FPHAX) is less diversified and has inherited sector risks associated with the fund
See Fidelity Select Pharmaceuticals Port Fund (FPHAX) performance details as of Jul 30, 2015

 

What do you think?

 

Compare Fidelity Select Pharmaceuticals Port Fund (FPHAX)Compare with other top Health category mutual funds

Aadditional top Health mutual funds for your consideration

FundYear to Date1 Year3 year5 year
Fidelity Select Pharmaceuticals Port21.3733.9229.7926.55
Franklin Biotechnology Discovery A (FBDIX)22.1050.3040.3335.10Compare
Hartford Healthcare A (HGHAX)18.9136.7032.5426.60Compare
Janus Global Life Sciences T (JAGLX)24.7147.4841.0532.06Compare

See top fund managers for Health Category Funds

 

Compare Fidelity Select Pharmaceuticals Port Fund (FPHAX)Compare with Health category ETFs

Some Health ETFs for your consideration

ETFYear to DateOne YearThree Year
SPDR S&P Biotech ETF (XBI)37.38%76.28%42.56%
First Trust NYSE Arca Biotech ETF (FBT)24.00%56.05%42.83%
iShares Nasdaq Biotechnology (IBB)26.12%52.56%42.18%
SPDR S&P Pharmaceuticals ETF (XPH)21.66%45.27%35.42%
Market Vectors Biotech ETF (BBH)21.27%44.49%41.44%

 

Graph of Fidelity Select Pharmaceuticals Port Fund (FPHAX) Net Asset TrackingFidelity Select Pharmaceuticals Port (FPHAX) Fund Net Asset

Track net asset change of Fidelity Select Pharmaceuticals Port fund (FPHAX)

DateNet Asset
07/2015$2.45B
05/2015$2.23B
04/2015$2.08B
More historic net asset information on Fidelity Select Pharmaceuticals Port Fund (FPHAX)

  

Graph of Fidelity Select Pharmaceuticals Port Fund (FPHAX) Portfolio TrackingFidelity Select Pharmaceuticals Port (FPHAX) Fund Portfolio Allocation

Track portfolio allocation change of Fidelity Select Pharmaceuticals Port fund (FPHAX)

DateCashStockBondOther
06/20151.46%98.53%0%0%
03/20152.17%97.8%0%0%
02/20151.3%98.67%0%0%
Click here to see more historic asset allocation information on Fidelity Select Pharmaceuticals Port Fund (FPHAX)

 

graph of Fidelity Select Pharmaceuticals Port Fund (FPHAX) Top 10 Position TrackingTop 10 Holdings in Fidelity Select Pharmaceuticals Port (FPHAX) Fund

Discover what Fidelity Select Pharmaceuticals Port Fund (FPHAX) manager is buying

Jun 29, 2015
Johnson & Johnson Common Stock [10.79%]
Allergan PLC [8.67%]
Sanofi ADR [6.83%]
AbbVie Inc. Common Stock [6.81%]
Bristol-Myers Squibb Company Co [5.49%]
Eli Lilly and Company Common St [5.01%]
Teva Pharmaceutical Industries [4.02%]
Novartis AG Common Stock [3.92%]
Novo Nordisk A/S Common Stock [3.73%]
Pfizer, Inc. Common Stock [3.23%]

Mar 30, 2015
Actavis PLC [10.01%]
Johnson & Johnson Common Stock [9.14%]
Sanofi ADR [7.66%]
AbbVie Inc. Common Stock [5.71%]
Bristol-Myers Squibb Company Co [5.7%]
Novo Nordisk A/S Common Stock [4.94%]
Novartis AG Common Stock [4.89%]
Teva Pharmaceutical Industries [4.09%]
Pfizer, Inc. Common Stock [3.19%]
Perrigo Company plc Ordinary Sh [2.96%]

Feb 27, 2015
Actavis PLC [8.74%]
Sanofi ADR [7.69%]
Johnson & Johnson Common Stock [7.24%]
Bristol-Myers Squibb Company Co [5.57%]
AbbVie Inc. Common Stock [5.36%]
Novartis AG Common Stock [4.86%]
VALEANT PHARMACEUTICALS INTL IN [4.74%]
Novo Nordisk A/S Common Stock [4.12%]
Teva Pharmaceutical Industries [3.93%]
Allergan Inc [3.3%]
Click here for Stock Holding Change Map in Fidelity Select Pharmaceuticals Port Fund (FPHAX)

  

Latest News on Fidelity Select Pharmaceuticals Port (FPHAX) Fund

See what is happening with Fidelity Select Pharmaceuticals Port Fund (FPHAX)

 

Fidelity Select Pharmaceuticals Port Fund (FPHAX) Related ResourcesSee more information on Fidelity Select Pharmaceuticals Port (FPHAX) Fund

Popular pages on Fidelity Select Pharmaceuticals Port (FPHAX) Fund

  

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update

Featured Advisor:
Travis D. Carter

Plano, TX
(972) 543-4800
More Details